Wassim Fares
Plus aucun poste en cours
Profil
Wassim Fares worked as a Senior Medical Director at Janssen Pharmaceuticals, Inc. and as a Chief Medical Officer at Bellerophon Therapeutics, Inc. He received a graduate degree from The University of North Carolina at Chapel Hill and undergraduate and doctorate degrees from the American University of Beirut.
Anciens postes connus de Wassim Fares
| Sociétés | Poste | Fin |
|---|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Directeur Technique/Scientifique/R&D | - |
Formation de Wassim Fares
| American University of Beirut | Doctorate Degree |
| The University of North Carolina at Chapel Hill | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
